| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 07/10/2008 | WO2008082488A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | WO2008082484A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/10/2008 | WO2008082009A2 Fused substituted aminopyrrolidine derivative |
| 07/10/2008 | WO2008081282A2 Process for the synthesis of n9-(3,5-dichloro-4-pyridyl)-6- difluoromethoxybenzo(4,5)furo(3,2-c)pyridine-9-carboxamide and salts thereof |
| 07/10/2008 | WO2008081010A1 Process for making asenapine |
| 07/10/2008 | WO2008080844A1 Azaspiro derivatives |
| 07/10/2008 | US20080167435 dimeric and polymeric compounds based upon fused ring tetracarboxylic imides, used as electronic thin films on substrates; transistors |
| 07/10/2008 | US20080167353 To treat viral infections and tumors; hepadnaviruses, flaviviruses, herpesviruses and human immunodeficiency virus; treating 3TC (L(-)SddC) resistant hepatitis B virus infections; 9-benzo[1,3]dioxol-5-yl-8-benzyloxymethyl-naphtho[1,2-d][1,3]dioxole-7-carboxylic acid benzyl ester |
| 07/10/2008 | US20080167341 1H-Benzimidazol-2-yl methyl)-piperidin-3-ylmethyl-(5,6,7,8-tetrahydro-quinolin-8-yl)-amine; fusin and chemokine receptors antagonist/agonist; increase progenitor and/or stem cells in humans; HIV, antiinflammatory agent: rheumatoid arthritis, inflammatory bowel disease |
| 07/10/2008 | US20080167332 Novel Compounds 243 |
| 07/10/2008 | US20080167299 menopause therapy; contraceptive; anticancer agents |
| 07/10/2008 | US20080166765 Fungal cell wall synthesis gene |
| 07/10/2008 | CA2710051A1 Substituted triazoles useful as axl inhibitors |
| 07/10/2008 | CA2674154A1 Azaspiro derivatives |
| 07/10/2008 | CA2673249A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 07/09/2008 | EP1941872A1 Use of TNF-alpha inhibitors for treating nerve root injury |
| 07/09/2008 | EP1940842A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/09/2008 | EP1940817A1 Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
| 07/09/2008 | EP1940516A2 Benzopyran and pyranopyridine derivatives as potassium channel openers |
| 07/09/2008 | EP1940411A2 Macroheterocylic compounds as kinase inhibitors |
| 07/09/2008 | EP1940401A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| 07/09/2008 | EP1399424B1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and 10,11-dihydro-10-0x0-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/09/2008 | EP1332133B1 Metabotropic glutamate receptor antagonists |
| 07/09/2008 | EP0984969B1 Fused dihydropyrans |
| 07/09/2008 | CN101215290A Method for synthesizing 11H-naphthol[1',2',5,6]pyran[2,3,d]pyridin-11(10H)-one compounds |
| 07/09/2008 | CN101215286A Tricyclic androgen receptor modulator compounds and methods |
| 07/09/2008 | CN100400523C Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 07/09/2008 | CN100400515C Isoquinoline derivatives and methods of use thereof |
| 07/09/2008 | CN100400055C Hotseason grow corydaline, its preparation method and its medicinal composition |
| 07/09/2008 | CN100400043C Utilization of galanthamine for the treatment of pathologies of the central nervous system owing to intoxications with psychotropic substances |
| 07/08/2008 | US7396932 Fusing a N-phenyl-C-leaving group-C-carbonyl- or oxycarbonylhydrazide with a 1-(p-nitrophhenyl)-3-halo-tetrahydro-2-piperidone; subsequent reactions include reduction and amidation of the nitro group and amidation of carbonyl or ester group; final products include factor Xa inhibitors |
| 07/08/2008 | US7396840 Chemokine receptor binding heterocyclic compounds |
| 07/08/2008 | US7396837 topoisomerase I inhibitors; stimulate topoisomerase I-mediated DNA cleavage and their cytotoxic potential; antitumor agent; prostate gland, ovaries, colon cancer; marine alkaloids |
| 07/08/2008 | CA2432131C Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2008 | CA2402364C Process for producing camptothecin |
| 07/03/2008 | WO2008079139A1 Abca1 elevating compounds |
| 07/03/2008 | WO2008078362A1 Antitumor agent and food containing the same |
| 07/03/2008 | WO2008077811A1 Spiro-piperidine derivatives |
| 07/03/2008 | WO2008077810A2 Spiro-piperidine derivatives |
| 07/03/2008 | US20080161571 Reacting 4-piperidino-piperidine with phosgene in methylene chloride; reduced dimers formed; intermediate for irinotecan |
| 07/03/2008 | US20080161334 Macrolides |
| 07/03/2008 | US20080161282 Cytotoxic agents and methods of use |
| 07/03/2008 | US20080160627 Environmental Sensitive Fluorogenic Compounds and Their Application for Singlet Oxygen and Protein Detection |
| 07/03/2008 | CA2674518A1 Spiro-piperidine derivatives |
| 07/03/2008 | CA2673307A1 Spiro-piperidine derivatives |
| 07/03/2008 | CA2672428A1 Abca1 elevating compounds |
| 07/02/2008 | EP1938823A1 Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
| 07/02/2008 | EP1937689A2 Intermediate and process of preparation of ecteinascidin such as ecteinascidines-583, 597 using such intermediate |
| 07/02/2008 | EP1937669A1 Novel benzopyran derivatives as potassium channel openers |
| 07/02/2008 | EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 07/02/2008 | EP1937268A2 Indenoisoquinolinone analogs and methods of use thereof |
| 07/02/2008 | EP1937068A2 Muscarinic acetylcholine receptor antagonists |
| 07/02/2008 | CN101213190A Compounds and compositions as TPO mimetics |
| 07/02/2008 | CN101210017A Synthesis of middle position-tetraaryldiphenanthrene dioxyporphyrin derivative and application thereof |
| 07/02/2008 | CN101210016A Heterocycle-fused morphinans compounds, preparation method and use thereof |
| 07/02/2008 | CN100398543C Method of preparing fugutoxin water extract |
| 07/02/2008 | CN100398519C Tetracyclic benzamide derivatives and methods of use thereof |
| 07/02/2008 | CN100398154C Remedies for psychoneurosis |
| 07/01/2008 | US7393955 Synthesis and use of tetracyclic benzamide derivatives; antidiabetic agents; coupling isochromene anhydride with cyanobenzene compound and performing ring substitution reactions |
| 07/01/2008 | US7393954 Process for the production of pentostatin aglycone and pentostatin |
| 07/01/2008 | US7393858 Tetrahydropyran compounds as tachykinin antagonists |
| 07/01/2008 | US7393848 Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/01/2008 | US7393844 Tetrahydropyranyl cyclopentyl heterocyclic amide modulators of chemokine receptor activity |
| 07/01/2008 | US7393551 Denatured carob flour (DCF) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 06/26/2008 | WO2008075565A1 Display element and method for driving the same |
| 06/26/2008 | WO2008074858A1 Intermediates and process for the production of 5-substituted tricyclic benzimidazoles |
| 06/26/2008 | WO2008074445A1 Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof |
| 06/26/2008 | US20080153899 Fatty amine drug conjugates |
| 06/26/2008 | US20080153864 Spiroazabicyclic Heterocyclic Compounds |
| 06/26/2008 | US20080153863 Spiropiperidine derivatives |
| 06/26/2008 | US20080153862 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases |
| 06/26/2008 | US20080153861 Vasopressin receptor (V1a) antagonists, treatment of anxiety and depressive disorders and other diseases |
| 06/26/2008 | US20080153821 Nitrogen-containing 5-membered ring compound |
| 06/26/2008 | US20080153820 pharmaceutically acceptable salt thereof or prodrug thereof, and the use thereof in therapy and in the treatment or prevention of a disorder in which the blocking of purine receptors, particularly adenosine receptors and more particularly A2A receptors, may be beneficial, |
| 06/26/2008 | US20080153801 Benzoxazepine compounds, their production and use |
| 06/25/2008 | EP1934228A2 Raf inhibitor compounds and methods of use thereof |
| 06/25/2008 | EP1730140B1 Opioid receptor antagonists |
| 06/25/2008 | EP1560834B1 New tricyclic derivatives as ltd4 antagonists |
| 06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
| 06/25/2008 | EP1173180B1 Camptothecin analogs and methods of preparation thereof |
| 06/25/2008 | CN101205231A Tetrahydroisoquinoline derivatives having multi-medicine resistance regulation activity and synthesis thereof |
| 06/25/2008 | CN100396686C Preparation method of Tetrandrine and Fangchino-kine |
| 06/25/2008 | CN100396682C Novel intermediate for preparing camptothecin derivative (CPT-11) and correlated compound and method thereof |
| 06/25/2008 | CN100396670C N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors, its pharmaceutical composition and use |
| 06/24/2008 | US7390930 Reacting triacetonamine and alcohol with gaseous hydrogen chloride ;ketalization |
| 06/24/2008 | US7390815 Pyrazole compounds useful as protein kinase inhibitors |
| 06/24/2008 | US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma |
| 06/19/2008 | WO2008073785A2 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 06/19/2008 | WO2008072801A1 Compounds with embedded benzopyran motif for core structures and preparation method thereof |
| 06/19/2008 | WO2008071765A1 Pharmaceutically active spiro-substituted benzimidazole derivatives |
| 06/19/2008 | WO2008071359A1 Substituted aminofuranones and their use |
| 06/19/2008 | WO2008070908A1 Chemical compounds and processes |
| 06/19/2008 | WO2008044027A3 Pharmaceutical compounds having hsp90 inhibitory or modulating activity |
| 06/19/2008 | US20080146740 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/19/2008 | US20080146644 Tricyclic Cytoprotective Compounds |
| 06/19/2008 | US20080146601 Method for making analgesics |
| 06/19/2008 | US20080146580 Anititumoral Ecteinascidin Derivatives |
| 06/19/2008 | US20080146571 potent deoxycytidine kinase inhibitors; O-linked pyrimidin-4-amine-based compounds |
| 06/19/2008 | DE102006059319A1 Substituierte Aminofuranone und ihre Verwendung Substituted aminofuranones and their use |
| 06/19/2008 | CA2672503A1 Substituted aminofuranones and their use |